VEGFA and spondylo-ocular syndrome: The aims of the current study were (1) to establish a murine model of SOS induced by oxaliplatin alone, (2) to investigate the protective effects of VEGF-inhibition in wild type and CD39-null mice, and (3) to analyze the impact of SOS on liver regeneration and liver damage after partial hepatectomy.